1.06

0.00% 0.00

Pharmacyte Biotech Inc (PMCB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Pharmacyte Biotech Inc stock is traded at $1.06, with a volume of 2,006. It is up +0.00% in the last 24 hours and up +0.00% over the past month. PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Previous Close:

$1.06

Open:

$1.01

24h Volume:

2,006

Relative Volume:

0.17

Market Cap:

$7.41M

Revenue:

Net Income/Loss:

$22.68M

P/E Ratio:

2.00

EPS:

0.53

Net Cash Flow:

$-1.94M

1W Performance:

-1.85%

1M Performance:

+0.00%

6M Performance:

-33.75%

1Y Performance:

-49.28%

1-Day Range:

$1.01

$1.0252

1-Week Range:

$1.00

$1.1257

52-Week Range:

$1.00

$2.4229

Pharmacyte Biotech Inc Stock (PMCB) Company Profile

Name

Pharmacyte Biotech Inc

Sector

Healthcare (1173)

Industry

Biotechnology (662)

Phone

(917) 595.2850

Address

23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS

Employee

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

PMCB's Discussions on Twitter

Compare PMCB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PMCB	2.24	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	0.4495	544.73M	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.68	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.148	318.66M	2.07B	-1.42B	-1.37B	-0.6765
SHMD Schmid Group N V	2.6781	118.42M	0	0	0	0.00
DAVEW Dave Inc	1.00	0	0	0	0	0.00

Pharmacyte Biotech Inc Stock (PMCB) Latest News

Jun 15, 2025

IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING - Barchart.com

Jun 15, 2025

Jun 14, 2025

Short Interest in PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Increases By 382.4% - Defense World

Jun 14, 2025

Jun 12, 2025

PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 3.8% – Here’s What Happened - Defense World

Jun 12, 2025

Jun 03, 2025

Malignant Ascites Pipeline 2025: Groundbreaking Clinical - openPR.com

Jun 03, 2025

May 21, 2025

PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 1.9% – What’s Next? - Defense World

May 21, 2025

May 18, 2025

PharmaCyte Biotech (NASDAQ:PMCB) & LadRx (OTCMKTS:CYTR) Head to Head Analysis - Defense World

May 18, 2025

May 07, 2025

Malignant Ascites Treatment Market Detailed In New Research - openPR.com

May 07, 2025

Apr 26, 2025

PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.7% – Still a Buy? - Defense World

Apr 26, 2025

Apr 24, 2025

PharmaCyte Biotech holds annual meeting, elects directors By Investing.com - Investing.com South Africa

Apr 24, 2025

PharmaCyte Biotech holds annual meeting, elects directors - Investing.com

Apr 24, 2025

Apr 17, 2025

PMCB stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa

Apr 17, 2025

PMCB stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia

Apr 17, 2025

Apr 04, 2025

PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 5.3% – Here’s What Happened - Defense World

Apr 04, 2025

Mar 31, 2025

Short Interest in PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Grows By 82.3% - Defense World

Mar 31, 2025

Mar 28, 2025

PMCB stock touches 52-week low at $1.38 amid market challenges - Investing.com India

Mar 28, 2025

Mar 17, 2025